Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline
- Development stage
- Unknown
- Lead developer
- Pfizer
- Modality
- Small Molecules
01
Overview
A synthetic small molecule with the molecular formula C24H18N4O and a molecular weight of 378.43 g/mol. It features a quinoline core linked via an ether bridge to a phenyl ring substituted with a pyrazole and pyridine moiety. The compound is classified as an experimental agent and belongs to the phenylpyrazole class of organic compounds. There are no approved indications or clinical trials reported for this molecule, and its mechanism of action has not been established in the literature or major drug databases as of June 2025. It is not approved for any therapeutic use and appears primarily in chemical interaction databases as a research compound.[7][1][2]
- Other names
- 2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-y)phenoxy]methyl}quinoline2-{[4-(pyridin-4-y)-1H-pyrazol]-3-y)phenoxymethyl}quinolineDB08386DB-08386DB 08386
Beyond the preview
Go deeper on 2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline.